http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0986394-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31180748b93559b2b9c9d6200e9b41e8 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2496-05 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate | 1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40913f0aedc7ad367daf570587c8753e |
publicationDate | 2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0986394-B1 |
titleOfInvention | Anti-coagulation of blood, blood plasma or synovial fluid products |
abstract | A method of anti-coagulating a blood, blood plasma or synovial fluid product comprising addition to the product iso-citrate is described. The method may further comprise adjustment of the calcium ion activity of the anti-coagulated product to physiological levels with a soluble calcium salt. Blood, blood plasma or synovial fluid products containing an anti-coagulating amount of anti-coagulant comprising iso-citrate, and optionally citrate, is disclosed. These anti-coagulated products are used for transport and storage of the products and/or for analysis of hemostatic or coagulative properties of the products. Additionally, blood sampling containers comprising isotonic or slightly hypertonic solutions of iso-citrate, and blood sampling containers comprising a solution of 0.1-0.5 M iso-citrate in one tenth of the container volume, and optionally an effective amount of calcium chloride resulting in a calcium ion activity of approximately 1 mM, are disclosed. Finally, reagents for analysis of blood, blood plasma or synovial fluid products comprising iso-citrate are described. |
priorityDate | 1997-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.